Is Haemonetics (HAE) Stock a Sell after Neil Ryding’s Insider Deal?; Voya Financial, Inc. (VOYA) Covered By 14 Bullish Analysts Last Week

May 24, 2018 - By Vivian Currie

Voya Financial, Inc. (NYSE:VOYA) Logo

Among 18 analysts covering Voya Financial (NYSE:VOYA), 14 have Buy rating, 1 Sell and 3 Hold. Therefore 78% are positive. Voya Financial had 49 analyst reports since August 26, 2015 according to SRatingsIntel. On Thursday, February 11 the stock rating was maintained by RBC Capital Markets with “Top Pick”. RBC Capital Markets maintained the stock with “Buy” rating in Monday, July 10 report. As per Tuesday, January 2, the company rating was maintained by BTIG Research. As per Monday, October 9, the company rating was maintained by RBC Capital Markets. The firm has “Buy” rating given on Tuesday, April 17 by Deutsche Bank. The firm has “Buy” rating given on Friday, June 23 by Keefe Bruyette & Woods. The firm has “Buy” rating given on Wednesday, May 2 by BTIG Research. The stock has “Buy” rating by Sandler O’Neill on Wednesday, January 10. The company was upgraded on Wednesday, January 20 by Bank of America. Wells Fargo upgraded the shares of VOYA in report on Monday, January 9 to “Outperform” rating. See Voya Financial, Inc. (NYSE:VOYA) latest ratings:

02/05/2018 Broker: BTIG Research Rating: Buy New Target: $59.0000 Maintain
02/05/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $59 New Target: $60 Maintain
25/04/2018 Broker: Credit Suisse Rating: Outperform New Target: $60 Initiates Coverage On
17/04/2018 Broker: Deutsche Bank Old Rating: Buy New Rating: Buy Old Target: $64 New Target: $66 Maintain
05/04/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $61 New Target: $59 Maintain
26/03/2018 Broker: Bank of America Rating: Buy New Target: $60.0000
01/03/2018 Broker: Wells Fargo Rating: Buy New Target: $63.0 Maintain
02/03/2018 Broker: UBS Rating: Buy New Target: $65 Initiates Coverage On
15/02/2018 Broker: SunTrust Rating: Hold
14/02/2018 Broker: RBC Capital Markets Rating: Buy New Target: $57.0 Maintain

Haemonetics Corporation (NYSE:HAE) Ratings Coverage

Among 10 analysts covering Haemonetics Corporation (NYSE:HAE), 4 have Buy rating, 0 Sell and 6 Hold. Therefore 40% are positive. Haemonetics Corporation has $100 highest and $28 lowest target. $55.67’s average target is -38.01% below currents $89.81 stock price. Haemonetics Corporation had 29 analyst reports since July 29, 2015 according to SRatingsIntel. Morgan Stanley maintained it with “Equal-Weight” rating and $43 target in Friday, October 6 report. The stock of Haemonetics Corporation (NYSE:HAE) has “Buy” rating given on Thursday, December 21 by Jefferies. Barrington Research upgraded Haemonetics Corporation (NYSE:HAE) on Tuesday, July 28 to “Outperform” rating. The rating was downgraded by CJS Securities to “Market Perform” on Tuesday, September 20. The company was maintained on Thursday, November 9 by Morgan Stanley. The firm has “Neutral” rating given on Monday, May 16 by Goldman Sachs. The firm has “Neutral” rating given on Monday, August 15 by Sidoti. As per Wednesday, May 9, the company rating was maintained by Morgan Stanley. The stock of Haemonetics Corporation (NYSE:HAE) earned “Buy” rating by Jefferies on Monday, January 8. As per Tuesday, June 20, the company rating was maintained by Jefferies.

Analysts await Haemonetics Corporation (NYSE:HAE) to report earnings on August, 6. They expect $0.42 EPS, up 27.27% or $0.09 from last year’s $0.33 per share. HAE’s profit will be $22.45 million for 53.46 P/E if the $0.42 EPS becomes a reality. After $0.43 actual EPS reported by Haemonetics Corporation for the previous quarter, Wall Street now forecasts -2.33% negative EPS growth.

More recent Haemonetics Corporation (NYSE:HAE) news were published by: Seekingalpha.com which released: “3Pea Is A Payment Processor With >40% Organic Growth Selling For Half Of Peer Multiples” on May 23, 2018. Also Streetinsider.com published the news titled: “Haemonetics (HAE) Names aid Bolorforosh CTO” on May 08, 2018. Globenewswire.com‘s news article titled: “Report: Developing Opportunities within Haemonetics, Arena Pharmaceuticals, Xperi, MoneyGram International, Boot ..” with publication date: May 15, 2018 was also an interesting one.

Haemonetics Corp EVP – Global Manufacturing and an insider Neil Ryding a few days ago sold 964 company shares having a total value $40,287 at the avg market share price of $41.8. At the moment, Neil Ryding owns 15,409 shares which are equivalent to exactly 0.03% of the company’s total market cap.

Since January 2, 2018, it had 0 buys, and 3 sales for $484,765 activity. On Tuesday, March 6 the insider Basil Michelle L sold $28,097. Another trade for 114 shares valued at $8,234 was sold by Scanlan Jacqueline. $448,434 worth of stock was sold by KROLL MARK W on Tuesday, January 2.

The stock decreased 1.06% or $0.96 during the last trading session, reaching $89.81. About 38,305 shares traded. Haemonetics Corporation (NYSE:HAE) has risen 82.56% since May 24, 2017 and is uptrending. It has outperformed by 71.01% the S&P500.

Investors sentiment decreased to 1.11 in Q4 2017. Its down 0.17, from 1.28 in 2017Q3. It worsened, as 20 investors sold Haemonetics Corporation shares while 77 reduced holdings. 48 funds opened positions while 60 raised stakes. 50.89 million shares or 3.15% less from 52.55 million shares in 2017Q3 were reported. Fisher Asset Mngmt Ltd Liability Corp has invested 0.02% in Haemonetics Corporation (NYSE:HAE). Capital Mgmt holds 1.47% in Haemonetics Corporation (NYSE:HAE) or 420,896 shares. Royal Bancorp Of Canada holds 737,428 shares. State Street holds 1.40M shares. Jacobs Levy Equity Mngmt Incorporated reported 0.01% in Haemonetics Corporation (NYSE:HAE). Loomis Sayles And Lp holds 0% or 710 shares. Acadian Asset Mngmt Limited Liability Company reported 0.13% stake. Ajo Limited Partnership has 883,494 shares. Martingale Asset Ltd Partnership holds 0.11% or 144,066 shares. Bnp Paribas Arbitrage Sa, a New York-based fund reported 21,989 shares. Pub Employees Retirement Association Of Colorado holds 0% in Haemonetics Corporation (NYSE:HAE) or 9,214 shares. Ubs Asset Mngmt Americas invested 0% in Haemonetics Corporation (NYSE:HAE). Envestnet Asset has 0% invested in Haemonetics Corporation (NYSE:HAE) for 26,665 shares. Tower Capital Ltd Liability (Trc) owns 677 shares. Everence Mngmt Incorporated has 3,650 shares for 0.05% of their portfolio.

Haemonetics Corporation, a healthcare company, provides hematology products and solutions. The company has market cap of $4.80 billion. The firm operates through five divisions: North America Plasma; Americas Blood Center and Hospital; Europe, Middle East and Africa; Asia Pacific; and Japan. It has a 105.66 P/E ratio. It offers plasma collection and storage products, including PCS brand plasma collection equipment and disposables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma clients to manage their donors, operations, and supply chain; Multicomponent Collection System brand apheresis equipment to collect specific blood components integrated from the donor; Automated Cell Processor brand solution to automate the washing and freezing of red cell components; and whole blood collection and processing products.

The stock decreased 0.97% or $0.52 during the last trading session, reaching $52.93. About 150,789 shares traded. Voya Financial, Inc. (NYSE:VOYA) has risen 34.91% since May 24, 2017 and is uptrending. It has outperformed by 23.36% the S&P500.

More notable recent Voya Financial, Inc. (NYSE:VOYA) news were published by: Seekingalpha.com which released: “Voya Financial: Bet On This Asset Gatherer” on May 20, 2018, also Benzinga.com with their article: “‘Attractive, Capital-Light’ Business Mix Makes Voya Financial A Potential Takeover Target, Says Credit Suisse” published on April 25, 2018, Globenewswire.com published: “Detailed Research: Economic Perspectives on Voya Financial, Dominion Energy, Incyte, MeetMe, Ventas, and Select …” on May 10, 2018. More interesting news about Voya Financial, Inc. (NYSE:VOYA) were released by: Investorplace.com and their article: “5 Top Stock Trades for Friday Morning” published on May 17, 2018 as well as Tucson.com‘s news article titled: “Voya Equity Closed End Funds Declare Distributions” with publication date: May 15, 2018.

Since February 21, 2018, it had 1 insider buy, and 2 sales for $369,684 activity. Nelson Charles P bought $698,439 worth of stock or 13,900 shares. SILVA KEVIN D sold $283,316 worth of Voya Financial, Inc. (NYSE:VOYA) on Tuesday, March 6.

Voya Financial, Inc. operates as a retirement, investment, and insurance firm in the United States. The company has market cap of $8.94 billion. It operates through five divisions: Retirement, Investment Management, Annuities, Individual Life, and Employee Benefits. It currently has negative earnings. The Retirement segment offers tax-deferred employer-sponsored retirement savings plans and administrative services in corporate, education, healthcare, and other non-profit and government entities; and rollover individual retirement accounts and other retail financial products, as well as financial planning and advisory services.

Haemonetics Corporation (NYSE:HAE) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>